Mesoblast (Mesoblast) Other Operating Expense : $-3.55 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Mesoblast Other Operating Expense?

Mesoblast's Other Operating Expense for the three months ended in Dec. 2023 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.55 Mil.

Mesoblast's quarterly Other Operating Expense increased from Jun. 2023 ($-0.23 Mil) to Sep. 2023 ($0.00 Mil) but then stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Mesoblast's annual Other Operating Expense increased from Jun. 2021 ($-1.56 Mil) to Jun. 2022 ($0.00 Mil) but then declined from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($-3.51 Mil).

Mesoblast Other Operating Expense Historical Data

The historical data trend for Mesoblast's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Other Operating Expense Chart

Mesoblast Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Operating Expense

Get a 7-Day Free Trial

0.33

-0.08

-1.56

-3.51

Mesoblast Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-	-3.32	-0.23	-	-

Mesoblast Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.55 Mil.

Mesoblast Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mesoblast's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesoblast (Mesoblast) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (NAS:MESO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

MEOBF:USA LWB:Germany MSB:Australia

Address

Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000

Website

https://www.mesoblast.com

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.